C82.39
Follicular lymphoma grade IIIa, extranodal and solid organ sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma is a type of blood cancer that originates in the lymphatic system, specifically affecting a type of white blood cell called lymphocytes. Grade IIIa indicates a more aggressive form of this disease, characterized by specific cell features. When classified as extranodal and involving solid organ sites, the lymphoma extends beyond the lymph nodes into other parts of the body, such as the spleen, liver, or other organs. This condition requires careful diagnosis and management by healthcare professionals. Understanding the nature of follicular lymphoma grade IIIa can help patients grasp the disease’s implications, potential treatment options, and the importance of medical consultation.
Causes & Symptoms
Clinical Causes: Genetic mutations that alter the behavior of lymphocytes Age-related changes in immune system function Environmental factors such as exposure to certain chemicals or radiation A family history of lymphomas or other blood cancers Weakened immune system conditions
Key Symptoms: Painless swelling or lumps in the neck, armpits, or groin Persistent fatigue or weakness Unexplained weight loss Fever and night sweats Difficulty breathing or chest discomfort if the lymphoma affects the chest organs Abdominal pain or swelling if organs like the liver or spleen are involved Loss of appetite
Diagnostic & Treatment
Diagnosis Path: Diagnosis of follicular lymphoma grade IIIa involves several steps:
Treatment Protocols: Treatment strategies for follicular lymphoma grade IIIa may include:
Clinical Advice & FAQs
Billing Guidance
Is C82.39 a billable ICD-10 code?
Yes, C82.39 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.39?
Clinical documentation must specify the nature of Follicular lymphoma grade IIIa, extranodal and solid organ sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference